Factor

Factor Capital Management Launches - Targets 30M Venture Fund I to Invest in Blockchain Technology Startups

Retrieved on: 
Thursday, November 2, 2023
Theta, Cosmos, Blockchain, Life, Investment, Factor, AI, Capital, Sigma Investments Group, Cryptocurrency, Neutral

The fund aims to invest up to $30m in seed-stage startups that leverage blockchain technology to solve real-world problems.

Key Points: 
  • The fund aims to invest up to $30m in seed-stage startups that leverage blockchain technology to solve real-world problems.
  • Venture Fund I is backed by a group of investors, including GSR Markets , Theta Capital Management , executives from Two Sigma Investments, and the founders of Multicoin Capital, Lattice Capital, and Cosmos Network, amongst others.
  • Blockchain technology has promised to change the way we conduct business by introducing trustless efficiencies in archaic analog systems.
  • While the early applications of blockchain technology were often associated with cryptocurrencies and speculation, the technology has come a long way since its inception.

Aviceda Completes Enrollment in Part 1 of the SIGLEC Phase 2/3 U.S. Clinical Trial; Initiation of Part 2 Imminent

Retrieved on: 
Monday, October 23, 2023
Technology, Research, Diabetes, Nanotechnology, Clinical Trials, Biotechnology, Health, Pharmaceutical, Science, Patient, SIGLEC, Macrophage, Injection, Microglia, Geographic atrophy, Inflammation, Factor, Senior, Pharmacokinetics, Growth, Clinical trial, American Academy, GA, American Academy of Ophthalmology, Aviceda, Safety, Therapy, Pharmaceutical industry, Ophthalmology

By repolarizing these immune cells to a resolution state, AVD-104 effectively reduces inflammation.

Key Points: 
  • By repolarizing these immune cells to a resolution state, AVD-104 effectively reduces inflammation.
  • Additionally, it enhances the activity of complement factor H, a crucial regulator of the complement cascade, to better regulate overamplification of the alternative complement cascade.
  • We are excited by our data to date and look forward for our larger clinical trial to start next month.”
    The SIGLEC U.S.
  • Part 1 of the trial is a multi-center, open label safety and dose escalation study that enrolled 30 participants.

Advances in Stroke Disease Market Insights: Expediting Drug Development, Epidemiology Study, Clinical Trial and Pipeline Assessment with DLI's Healthcare Consulting Services | Disease Landscape Insights

Retrieved on: 
Wednesday, October 11, 2023
Diagnosis, Walking, Smoking, Drug development, Centers for Disease Control and Prevention, Death, Stroke, Aspirin, Bleeding, Cell death, Public, Medicine, Prevalence, Brain, Factor, Intraparenchymal hemorrhage, Therapy, DSM-IV codes, Brain damage, Arm, Grim – Stroke – Disease, Diabetes, Headache, Sleep deprivation, Rehabilitation, Weakness, Speech, Signs and symptoms, Plaque, Dizziness, Leg, Hypoesthesia, Thrombolysis, Confusion, DLI, Face, Patient, Risk, Dietary supplement, Pharmaceutical industry

According to a stroke statistic released by the Center for Disease Control and Prevention, a person dies of stroke in every 3 minutes and 14 seconds worldwide.

Key Points: 
  • According to a stroke statistic released by the Center for Disease Control and Prevention, a person dies of stroke in every 3 minutes and 14 seconds worldwide.
  • There are two primary types of strokes, i.e., ischemic and haemorrhagic stroke.
  • Ishemic stroke which occurs when a blood clot or plaque buildup narrows or blocks an artery supplying blood to the brain.
  • DLI's healthcare consulting services have been instrumental in advancing the understanding of stroke disease, expediting drug development, conducting epidemiological research, assessing clinical trials, and broadening product offerings.

Advances in Stroke Disease Market Insights: Expediting Drug Development, Epidemiology Study, Clinical Trial and Pipeline Assessment with DLI's Healthcare Consulting Services | Disease Landscape Insights

Retrieved on: 
Wednesday, October 11, 2023
Diagnosis, Walking, Smoking, Drug development, Centers for Disease Control and Prevention, Death, Stroke, Aspirin, Bleeding, Cell death, Public, Medicine, Prevalence, Brain, Factor, Intraparenchymal hemorrhage, Therapy, DSM-IV codes, Brain damage, Arm, Grim – Stroke – Disease, Diabetes, Headache, Sleep deprivation, Rehabilitation, Weakness, Speech, Signs and symptoms, Plaque, Dizziness, Leg, Hypoesthesia, Thrombolysis, Confusion, DLI, Face, Patient, Risk, Dietary supplement, Pharmaceutical industry

According to a stroke statistic released by the Center for Disease Control and Prevention, a person dies of stroke in every 3 minutes and 14 seconds worldwide.

Key Points: 
  • According to a stroke statistic released by the Center for Disease Control and Prevention, a person dies of stroke in every 3 minutes and 14 seconds worldwide.
  • There are two primary types of strokes, i.e., ischemic and haemorrhagic stroke.
  • Ishemic stroke which occurs when a blood clot or plaque buildup narrows or blocks an artery supplying blood to the brain.
  • DLI's healthcare consulting services have been instrumental in advancing the understanding of stroke disease, expediting drug development, conducting epidemiological research, assessing clinical trials, and broadening product offerings.

Octapharma USA Presents Factor Concentrates for Perioperative Bleeding Symposium for ASA Annual Meeting Attendees

Retrieved on: 
Tuesday, October 10, 2023
Annual general meeting, Thrombophilia, Algorithm, American Society of Anesthesiologists, Disease, Food, VKA, Bleeding, PST, MD, Society, Mortality, Factor, Hospital, FDA, Food and Drug Administration, Warfarin, Toronto General Hospital, PCC, FC, Octapharma, Duke University, Hemostasis, The Reconstruction (1970 film), ASA, Moscone Center, Toronto, Patient, Nightclub, Dentistry, Pharmaceutical industry, Fibrinogen, Research

PARAMUS, N.J., Oct. 10, 2023 /PRNewswire/ -- Octapharma USA will sponsor the scientific symposium, Factor Concentrates for Perioperative Bleeding – Global Perspectives, Sunday, October 15th in conjunction with the American Society of Anesthesiologists (ASA) Annual Meeting in San Francisco.

Key Points: 
  • PARAMUS, N.J., Oct. 10, 2023 /PRNewswire/ -- Octapharma USA will sponsor the scientific symposium, Factor Concentrates for Perioperative Bleeding – Global Perspectives, Sunday, October 15th in conjunction with the American Society of Anesthesiologists (ASA) Annual Meeting in San Francisco.
  • The symposium will address current gaps in research related to factor concentrates, including prothrombin complex concentrates (PCC) and fibrinogen concentrates (FC), for perioperative bleeding management.
  • Kamrouz Ghadimi, MD, MHSc, Department of Anesthesiology, Duke University, will discuss, "Perioperative Coagulopathic Bleeding – Definition, Treatment Algorithms, and POC Testing, Oh My!"
  • The role of factor concentrates and blood products for management of bleeding in surgery;
    The latest research and current practice guidelines for factor concentrates in perioperative bleeding; and
    Individualized bleeding management strategies in cardiac surgery, with patient case presentations.

Virtusa Acquires Factor Creative LLC, Amplifying Creative and Martech Offerings for Enterprises

Retrieved on: 
Monday, September 11, 2023
Workforce, Martech, Partnership, Information technology, Engineering, Marketing, Factor, Creativity, Acquisition, CRM, Sales, Virtusa

SOUTHBOROUGH, Mass., Sept. 11, 2023 /PRNewswire/ -- Virtusa Corporation, a global provider of digital strategy, digital engineering, and information technology (IT) services, today announced an expansion to its service portfolio through the acquisition of Factor Creative LLC, a prominent full-service creative agency based in Walnut Creek, CA.

Key Points: 
  • This acquisition will enable Virtusa to create a more comprehensive end-to-end martech offering for clients with the addition of brand identity & strategy, creative, and marketing analytics services focused on the creation of useful, meaningful digital experiences for end customers.
  • With a workforce of creative experts, Factor has established itself as a reputable provider of inventive solutions within the domain of CRM email campaigns, website design, and conventional creative and brand identity services catering to technology enterprises.
  • The agency's artistic expertise has significantly propelled business innovation and achieved remarkable client results throughout the last decade.
  • "Embracing this milestone, Factor and Virtusa's collaboration signifies a convergence of creativity and technology," noted Kareem Fahmi, CEO and Founding Partner at Factor.

EQS-News: Biotest AG: Biotest increases EBIT to Euro 19.8 million in the first half of 2023

Retrieved on: 
Thursday, August 10, 2023
Transfer, Biologics license application, Saskatchewan River Sturgeon Management Board, US Foods, Technology transfer, Grifols, Community-acquired pneumonia, S.A, Tax, Fibrinogen, EBT, Research, EBIT, Plasma, Board of Management St. Molaga's National School v The Secretary General of the Department of Education and Science, Patient, EAT, Factor, Management, Phase, FDA, III, BLA, Food, Pharmaceutical industry

The Biotest Group's total earnings after tax (EAT) increased to € 1.7 million in the first half of 2023 (same period of the previous year: € - 19.9 million) in view of the influencing factors described.

Key Points: 
  • The Biotest Group's total earnings after tax (EAT) increased to € 1.7 million in the first half of 2023 (same period of the previous year: € - 19.9 million) in view of the influencing factors described.
  • This results in earnings per ordinary share of € 0.03 after € - 0.50 in the first half of 2022.
  • Biotest develops Fibrinogen not only for congenital but also for acquired fibrinogen deficiency.
  • This increase in sales is possible due to the commissioning of the Yimmugo® production facility within Biotest Next Level.

Q4 Inc. Reports Strong Progress in Second Quarter 2023 Results

Retrieved on: 
Wednesday, August 9, 2023
Professional Services, Communications, Technology, Mobile, Wireless, Finance, Internet, Public Relations, Investor Relations, Perception, Tax, Growth, G&A, Research, Factor, Marketing, Bank statement, SEDAR

Our key performance indicators may be calculated in a manner different from similar key performance indicators used by other companies.

Key Points: 
  • Our key performance indicators may be calculated in a manner different from similar key performance indicators used by other companies.
  • Definitions of these key performance indicators can be found under the heading “Key Performance Indicators” in the Company’s management’s discussion and analysis for the three months ended March 31, 2023 and 2022.
  • This press release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking information”) within the meaning of applicable securities laws.
  • Additional information relating to Q4, can be found on SEDAR under the Company’s profile at www.sedar.com .

USD 47 billion Growth in API Management Market Size - Industry Analysis, Market Trends, Market Growth, Opportunities

Retrieved on: 
Wednesday, July 19, 2023
Cloud, Component, API management, Find, Service, Non-bank financial institution, OPC Historical Data Access, API, Record, Apigee, Research, Privacy, Information technology, USD, Final good, Student, Documentation, Publishing, Strategic management, Small, Application, Systemically important financial institution, Knowledge, Region, Statistical Research Group, Deployment, Small and medium enterprises in Mexico, Factor, Speciality chemicals, Fine chemical, Video game, Retail, MuleSoft, Others

Another critical part of API management is the analysis of API systems in a safe and secure environment.

Key Points: 
  • Another critical part of API management is the analysis of API systems in a safe and secure environment.
  • Furthermore, the API gateway is another essential feature of modern-age API management systems.
  • The API Management market size was worth around USD 5.4 billion in 2021 and is estimated to hit approximately USD 47 billion by 2030.
  • Additionally, the global market is projected to benefit from the rising e-commerce industry which is currently one of the largest consumers of API management programs.

USD 47 billion Growth in API Management Market Size - Industry Analysis, Market Trends, Market Growth, Opportunities

Retrieved on: 
Wednesday, July 19, 2023
Cloud, Component, API management, Find, Service, Non-bank financial institution, OPC Historical Data Access, API, Record, Apigee, Research, Privacy, Information technology, USD, Final good, Student, Documentation, Publishing, Strategic management, Small, Application, Systemically important financial institution, Knowledge, Region, Statistical Research Group, Deployment, Small and medium enterprises in Mexico, Factor, Speciality chemicals, Fine chemical, Video game, Retail, MuleSoft, Others

Another critical part of API management is the analysis of API systems in a safe and secure environment.

Key Points: 
  • Another critical part of API management is the analysis of API systems in a safe and secure environment.
  • Furthermore, the API gateway is another essential feature of modern-age API management systems.
  • The API Management market size was worth around USD 5.4 billion in 2021 and is estimated to hit approximately USD 47 billion by 2030.
  • Additionally, the global market is projected to benefit from the rising e-commerce industry which is currently one of the largest consumers of API management programs.